COVID-19: Key metrics ranked by state

Article

Unemployment, economies, and response aggressiveness compared.

With data obtained from the U.S. Department of Labor, WalletHub compiled several rankings of all 50 states, plus the District of Columbia, in order to reveal the regional impact of COVID-19.

Some states excel at keeping unemployment low. Some soar in response aggressiveness or economic recovery.

Related: Companies offer CE, other resources amid coronavirus pandemic

Louisiana ranked as one of the most vulnerable states, topping the lists of most exposed economies and biggest increase in unemployment.  New York has been most aggressive in limiting virus exposure, followed by the District of Columbia, Alaska and Hawaii.

On the other end, Oklahoma, South Dakota, Alabama and Wyoming have been least aggressive.

Unemployment metrics were based on increases in unemployment insurance initial claims for several key weeks. Response aggressiveness was determined through evaluation across three key dimensions, “Prevention & Containment,” “Risk Factors & Infrastructure” and “Economic Impact.” High impact industries, workforce and resources for businesses to cope better with the crisis were considered when ranking each state’s economic exposure to the pandemic.

Here are the 50 states listed alphabetically, with rankings for each metric. For links to the full articles and more information on how results were gathered, click here, here and here.

More by Brooke Beery: IACLE’s 2020 award winners announced

 

 

Recent Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Khanh Hoang at EyeCon 2024 receiving the Visionary in Eye Care Award
Dr Adam Wenick at EyeCon 2024
David Chin Yee, MD, at EyeCon 2024
Dr. Adam Ramsey discusses innovation for your eye care practice at EyeCon 2024
Dr. Leonard Messner at EyeCon 2024
Dr. Adam Wenick at EyeCon 2024
EyeCon 2024: Insights on transforming ocular surface disease management
© 2024 MJH Life Sciences

All rights reserved.